Two new appointments at Aqua-Chem

Two appointments, including chief finance officer (CFO), were announced by Aqua-Chem Inc, manufacturer of membrane and thermal water treatment technologies.

Thomas Gillcrist was named as CFO and Ron Shook as pharmaceutical applications engineer. They will report directly to David Gensterblum, president and CEO.

Gillcrist comes to Aqua-Chem from CustoMatrix Inc, where he successfully served as a principal in strategic services for the past five years. Prior to that, he held upper-level management positions at Axeon Water Technologies, Tech M3, Ionics, Microbar Inc and US Filter.

Shook joined Aqua-Chem in 2011 as business development manager for the Pharmaceutical/Biotech and Beverage Divisions. He has held high-profile technical and management positions within the semi-conductor, pharmaceutical and biotech industries, specializing in the design, operation and maintenance of high purity water and critical utility systems.

“Tom and Ron are valuable additions to the Aqua-Chem management team and provide valuable support for the implementation of our growth strategy,” Gensterblum said. “Tom has great experience in meeting the finance needs of companies with proprietary technology, and Ron’s background in the pharmaceutical and biotech sectors is a great fit for our Pharmaceutical / Biotech and Beverage Divisions. I look forward to working with them both.”